The abnormal expression of DSC3, DSG3, and β-catenin was found in oral carcinomas and that the reduced or absent expression of β-catenin had a positive correlation with reduced or absent expression of DSC3 in 24 patients with lymph node metastasis [106]. This evidence concerns the gene DSG3 and metastatic malignant neoplasm in the lymph nodes.